Continue Haloperidol Perioperatively
For a patient on haloperidol 5 mg TID, continue the medication through the morning of surgery, including the day of operation. This is the standard recommendation for antipsychotic medications in the perioperative period 1, 2, 3.
Rationale for Continuation
Antipsychotic medications like haloperidol should generally be maintained perioperatively to:
- Prevent acute withdrawal symptoms
- Maintain psychiatric stability
- Avoid decompensation of the underlying psychiatric condition
The evidence consistently supports continuing chronic psychotropic medications rather than abruptly stopping them before surgery 1, 4, 5.
Critical Anesthetic Considerations
QT Prolongation Risk
Haloperidol carries significant risk for QT interval prolongation and torsades de pointes 6. Before proceeding:
- Obtain baseline ECG to assess QT interval
- Avoid combining with other QT-prolonging agents (certain antibiotics, ondansetron, metoclopramide)
- Consider alternative antiemetics if needed
- Monitor for arrhythmias intraoperatively
Cardiovascular Effects
Expect potential for:
- Hypotension (especially with induction agents)
- Bradycardia
- Enhanced response to anesthetic agents 7, 3
Neuroleptic Malignant Syndrome (NMS)
Maintain vigilance for NMS, particularly with:
Anesthetic Agent Selection
Recommended Approach:
- Avoid or use cautiously: Droperidol, metoclopramide, ondansetron (all prolong QT)
- Preferred opioids: Fentanyl, remifentanil, hydromorphone
- Avoid: Meperidine (increased risk of serotonin syndrome and seizures) 7
- Regional anesthesia: Strongly consider when feasible to minimize systemic drug interactions 8
Sedation Considerations:
- Haloperidol has additive CNS depressant effects with anesthetics
- May require reduced doses of induction agents and volatile anesthetics
- Anticipate prolonged emergence 3
Postoperative Management
Delirium Prevention:
Haloperidol may be beneficial for treating postoperative delirium if the patient becomes severely agitated 9, 6. However:
- Use lowest effective dose (0.5-1 mg in elderly/debilitated patients) 10, 11
- Avoid as first-line for hypoactive delirium 9
- Benzodiazepines should NOT be first-line for delirium-associated agitation 9
Resume Regular Dosing:
- Restart haloperidol 5 mg TID as soon as patient can tolerate oral intake
- If NPO prolonged, consider parenteral haloperidol (bioequivalence: use previous 24-hour oral dose as guide) 10
- Resume within 12-24 hours of last dose to maintain therapeutic levels
Common Pitfalls to Avoid
- Do not abruptly discontinue - Risk of psychiatric decompensation outweighs surgical concerns
- Do not combine multiple QT-prolonging agents - Check all perioperative medications for this interaction
- Do not use high-dose haloperidol without ECG monitoring - Arrhythmia risk increases with dose 6
- Do not assume standard anesthetic doses - Anticipate enhanced sedation and cardiovascular effects